View Item 

Show simple item record

Cause of Death in Older Men After the Diagnosis of Prostate Cancer

dc.contributor.authorKetchandji, Melanieen_US
dc.contributor.authorKuo, Yong-Fangen_US
dc.contributor.authorShahinian, Vahakn B.en_US
dc.contributor.authorGoodwin, James S.en_US
dc.date.accessioned2010-04-01T15:36:41Z
dc.date.available2010-04-01T15:36:41Z
dc.date.issued2009-01en_US
dc.identifier.citationKetchandji, Melanie; Kuo, Yong-Fang; Shahinian, Vahakn B.; Goodwin, James S. (2009). "Cause of Death in Older Men After the Diagnosis of Prostate Cancer." Journal of the American Geriatrics Society 57(1): 24-30. <http://hdl.handle.net/2027.42/66098>en_US
dc.identifier.issn0002-8614en_US
dc.identifier.issn1532-5415en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/66098
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19054189&dopt=citationen_US
dc.description.abstractTo compare survival and cause of death in men aged 65 and older diagnosed with prostate cancer and with survival and cause of death in a noncancer control population. DESIGN : Retrospective cohort from a population-based tumor registry linked to Medicare claims data. SETTING : Eleven regions of the Surveillance, Epidemiology and End Results (SEER) Tumor Registry. PARTICIPANTS : Men aged 65 to 84 (N=208,601) diagnosed with prostate cancer from 1988 through 2002 formed the basis for different analytical cohorts. MEASUREMENTS : Survival as a function of stage and tumor grade (low, Gleason grade<7; moderate, grade=7; and high, grade=8–10) was compared with survival in men without any cancer using Cox proportional hazards regression. Cause of death according to stage and tumor grade were compared using chi-square statistics. RESULTS : Men with early-stage prostate cancer and with low- to moderate-grade tumors (59.1% of the entire sample) experienced a survival not substantially worse than men without prostate cancer. In those men, cardiovascular disease and other cancers were the leading causes of death. CONCLUSION : The excellent survival of older men with early-stage, low- to moderate-grade prostate cancer, along with the patterns of causes of death, implies that this population would be well served by an ongoing focus on screening and prevention of cardiovascular disease and other cancers.en_US
dc.format.extent149049 bytes
dc.format.extent3110 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Incen_US
dc.rightsJournal compilation 2009 The American Geriatrics Society/Wiley Periodicals, Inc.en_US
dc.subject.otherProstate Canceren_US
dc.subject.otherMortalityen_US
dc.subject.otherSurvival and Comorbiditiesen_US
dc.titleCause of Death in Older Men After the Diagnosis of Prostate Canceren_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelGeriatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan.en_US
dc.contributor.affiliationotherUniversity of Texas Medical Branch, Galveston, Texas ;en_US
dc.contributor.affiliationotherSealy Center on Aging ; anden_US
dc.identifier.pmid19054189en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/66098/1/j.1532-5415.2008.02091.x.pdf
dc.identifier.doi10.1111/j.1532-5415.2008.02091.xen_US
dc.identifier.sourceJournal of the American Geriatrics Societyen_US
dc.identifier.citedreferenceCarver JR, Shapiro CL, Ng A et al. Review on the ongoing care of adult cancer survivors : Cardiac and pulmonary late effects. J Clin Oncol 2007 ; 25 : 3991 – 4008.en_US
dc.identifier.citedreferenceFleming ST, Pearce KA, McDavid K et al. The development and validation of a comorbidity index for prostate cancer among black men. J Clin Epidemiol 2003 ; 56 : 1064 – 1075.en_US
dc.identifier.citedreferenceBabb P, Quinn M. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. BJU Int 2002 ; 90 : 174 – 184.en_US
dc.identifier.citedreferencePotosky AL, Merill RM, Riley GF et al. Prostate cancer treatment and ten-year survival among group/Staff HMO and fee-for-service Medicare patients. Health Serv Res 1999 ; 34 : 1683 – 1691.en_US
dc.identifier.citedreferenceRobinson D, Aus G, Bak J et al. Long-term follow-up of conservatively managed incidental carcinoma of the prostate : A multivariate analysis of prognostic factors. Scand J Urol Nephrol 2007 ; 41 : 103 – 109.en_US
dc.identifier.citedreferenceWong YN, Mitra N, Hudes G et al. Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA 2006 ; 296 : 2683 – 2693.en_US
dc.identifier.citedreferencePotosky AL, Riley GF, Lubitz JD et al. Potential for cancer health services research using a linked medicare-tumor registry database. Med Care 1993 ; 31 : 732.en_US
dc.identifier.citedreferenceSox HC, Mulrow C. An editorial update : Should benefits of radical prostatectomy affect the decision to screen for early prostate cancer? Ann Intern Med 2005 ; 143 : 232 – 233.en_US
dc.identifier.citedreferenceKlabunde CN, Potosky AL, Legler JM et al. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000 ; 53 : 1258 – 1267.en_US
dc.identifier.citedreferenceSatariano WA, Ragland KE, Van Den Eden SK. Cause of death in men diagnosed with prostate cancinoma. Cancer 1998 ; 83 : 1179 – 1184.en_US
dc.identifier.citedreference11.  Deaths : Leading causes for 2004. Natl Vital Stat Rep 2007 ; 56 : 1 – 95.en_US
dc.identifier.citedreferenceNewschaffer CJ, Otani K, McDonald MK et al. Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort. J Natl Cancer Inst 2000 ; 92 : 613 – 621.en_US
dc.identifier.citedreferenceLu-Yao G, Stukel TA, Yao SL. Changing patterns in competing causes of death in men with prostate cancer : A population based study. J Urol 2004 ; 171 : 2285 – 2290.en_US
dc.identifier.citedreferenceFitzpatrick JM. Management of localized prostate cancer in senior adults : The crucial role of comorbidity. BJU Int 2008 ; 101 ( Suppl 2 ) : 16 – 22.en_US
dc.identifier.citedreferenceTewari A, Johnson CC, Divine G et al. Long-term survival probability in men with clinically localized prostate cancer : A case-control, propensity modeling study stratified by race, age, treatment and comorbidities. J Urol 2004 ; 171 : 1513 – 1519.en_US
dc.identifier.citedreferenceShahinian VB, Kuo YF, Freeman JL et al. Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma. Cancer 2005 ; 103 : 1615 – 1624.en_US
dc.identifier.citedreferenceD'Amico AV, Denham JW, Crook J et al. Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol 2007 ; 25 : 2420 – 2425.en_US
dc.identifier.citedreferenceKeating NL, O'Malley AJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 2006 ; 24 : 4448 – 4456.en_US
dc.identifier.citedreferenceHaidar A, Yassin A, Saad F et al. Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes. Aging Male 2007 ; 10 : 189 – 196.en_US
dc.identifier.citedreferenceD'Amico AV, Chen MH, Renshaw AA et al. Androgen suppression and radiation vs radiation alone for prostate cancer : A randomized trial. JAMA 2008 ; 299 : 289 – 295.en_US
dc.identifier.citedreferenceEarle C, Neville B. Under use of necessary care among cancer survivors. Cancer 2004 ; 101 : 1712 – 1719.en_US
dc.identifier.citedreferenceEarle CC, Burstein HJ, Winer EP et al. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol 2003 ; 21 : 1447 – 1451.en_US
dc.identifier.citedreferenceWelch HG, Albertsen PC, Nease RF et al. Estimating treatment benefits for the elderly : The effect of competing risks. Ann Intern Med 1996 ; 124 : 577 – 584.en_US
dc.identifier.citedreferenceJemal A, Clegg LX, Ward E et al. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer 2004 ; 101 : 3 – 27.en_US
dc.identifier.citedreferencePenson D, Albertsen PC, Nelson PS et al. Determining cause of death in prostate cancer : Are death certificates valid? J Nat Cancer Inst 2001 ; 93 : 1822 – 1823.en_US
dc.identifier.citedreferenceAlbertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005 ; 293 : 2095 – 2101.en_US
dc.identifier.citedreferenceGirodano SH, Kuo YF, Duan Z et al. Limits of observational data in determining outcomes from cancer therapy. Cancer 2008 ; 112 : 2456 – 2466.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1532-5415.2008.02091.x.pdf
Size:
145.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.